Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Newer glucose‐lowering drugs and risk of dementia: A systematic review and meta‐analysis of observational studies
Huilin Tang, Hui Shao, C. Elizabeth Shaaban, et al.
Journal of the American Geriatrics Society (2023) Vol. 71, Iss. 7, pp. 2096-2106
Closed Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

Neuroprotective effects of SGLT2 inhibitors empagliflozin and dapagliflozin on Aβ 1–42 -induced neurotoxicity and neuroinflammation in cellular models of Alzheimer's disease
Mehdi Alami, Echarki Zerif, Abdelouahed Khalil, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Cardioprotective Glucose-Lowering Agents and Dementia Risk
Allie Seminer, Alfredi Mulihano, Clare O’Brien, et al.
JAMA Neurology (2025)
Closed Access
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders
Riccardo De Giorgi, Ana Ghenciulescu, Courtney Yotter, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335593
Closed Access
Glycated hemoglobin and body mass index as mediators of GLP‐1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes
Huilin Tang, William T. Donahoo, Steven T. DeKosky, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access
Sodium‐glucose cotransporter‐2 inhibitors and subtype‐specific dementia risk: A multinational and multiethnic cohort study
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Comparative study of SGLT2 inhibitors and metformin: evaluating first-line therapies for dementia prevention in type 2 diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Diabetes & Metabolism (2025), pp. 101655-101655
Closed Access
A State-of-Art Review of the Vicious Circle of Sleep Disorders, Diabetes and Neurodegeneration Involving Metabolism and Microbiota Alterations
Salvatore Versace, Gaia Pellitteri, Roberto Sperotto, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10615-10615
Open Access | Times Cited: 10
Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems—A Literature Review
Viviana Elian, Violeta Popovici, Oana Karampelas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1972-1972
Open Access | Times Cited: 3
An Updated Prioritization of Geroscience- Guided FDA-Approved Drugs Repurposed to Target Aging
Michael Leone, Nir Barzilai
Medical Research Archives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Conquering Insulin Network Dysfunctions in Alzheimer’s Disease: Where Are We Today?
Suzanne M. de la Monte
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S317-S343
Closed Access | Times Cited: 3
Is it time to repurpose geroprotective diabetes medications for prevention of dementia?
Diana He, Sandra Aleksić
Journal of the American Geriatrics Society (2023) Vol. 71, Iss. 7, pp. 2041-2045
Open Access | Times Cited: 9
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues
Vera Battini, María Antonietta Barbieri, Carla Carnovale, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3417-3425
Open Access | Times Cited: 2
Individualized treatment of diabetes mellitus in older adults
Atsushi Araki
Geriatrics and gerontology international/Geriatrics & gerontology international (2024) Vol. 24, Iss. 12, pp. 1257-1268
Open Access | Times Cited: 2
New Insights into the Role of SGLT-2 Inhibitors in the Prevention of Dementia
Cheng‐Hsien Hung, Li‐Yu Lu
Neurology International (2024) Vol. 16, Iss. 6, pp. 1717-1730
Open Access | Times Cited: 2
Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health
Raj N. Kalaria, Rufus Akinyemi, Stella‐Maria Paddick, et al.
Expert Review of Neurotherapeutics (2023) Vol. 24, Iss. 1, pp. 25-44
Open Access | Times Cited: 6
Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease
Noor Abdulhameed, Alice Babin, Kim M. Hansen, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Peripheral insulin resistance attenuates cerebral glucose metabolism and impairs working memory in healthy adults
Hamish A Deery, Emma X Liang, Robert Di Paolo, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Translational research on cognitive impairment in chronic kidney disease
Carsten A. Wagner, Ziad A. Massy, Giovambattista Capasso, et al.
Nephrology Dialysis Transplantation (2024)
Closed Access | Times Cited: 1
Exploring the Therapeutic Potential of DPP4 Inhibitors in Alzheimer's Disease: Molecular Insight and Clinical Outcome
Albert Joseph Sulangi, Sarah E. Lyons, Ahmed Ms Abdou, et al.
Cureus (2024)
Open Access | Times Cited: 1
Dysregulation of energy metabolism in Alzheimer's disease
Yue Yuan, Gang Zhao, Yang Zhao
Journal of Neurology (2024) Vol. 272, Iss. 1
Open Access | Times Cited: 1
Meta-analysis of association between diabetes therapy and dementia
Michael Jecht
Deleted Journal (2024) Vol. 20, Iss. 3, pp. 465-468
Closed Access
Pre-Diagnosis Observational and Prescription History associated with Alzheimer's Disease Incidence
Gareth Williams
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Newer glucose‐lowering drugs reduce the risk of late‐onset seizure and epilepsy: A meta‐analysis
Udeept Sindhu, Akshay Sharma, Ifrah Zawar, et al.
Epilepsia Open (2024)
Open Access
Diabetes treatment: beyond glycemia
Hugo Gutiérrez-Hermosillo, Enrique Díaz de León González
Geriatrics and gerontology international/Geriatrics & gerontology international (2024)
Open Access
The Promising Potency of Sodium–Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients
Yibin Zhang, Xiao-xing Liao, Jialu Xu, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2783-2783
Open Access

Scroll to top